Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IPO Update: Pace Of US Offerings Slows As 13 Biopharmas Go Public In 2019

Executive Summary

With about three IPOs per month compared with a pace of nearly six per month in 2018, drug developers have raised $1.55bn with US offerings this year – though returns have been mixed.

Advertisement

Related Content

Finance Watch: Arteaus Comes Full Circle As Investors Monetize Emgality Royalties
J.P. Morgan 2019: Biopharma Sentiment Soars As Deal And Financing Optimism Abounds
Deal Watch: Cancer Remains Hot Target At J.P. Morgan
IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year
Deal Watch: Amgen Outsources Celiac Drug To Provention; Lilly, NextCure Will Co-Discover IO Drugs
Deal Watch: Allergan, Celgene, AstraZeneca Among Biopharmas Advancing Existing Partnerships
Finance Watch: Despite Bad News, IPOs And Public Offerings Keep Flowing
Finance Watch: Semma Raises $114m As VC Funding Keeps Up Brisk Pace
Bicycle Partners With Biogen Spinout Against Rare Blood Disorders
Finance Watch: Bicycle Spins Toward Clinic With $52m Round; Stock Spikes Spur Offerings

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC125158

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel